BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Salgado JV, Goes MA, Salgado Filho N. FGF21 and Chronic Kidney Disease. Metabolism 2021;118:154738. [PMID: 33617873 DOI: 10.1016/j.metabol.2021.154738] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Chiu L, Wang C, Lin Y, Hsu B. Association of serum fibroblast growth factor 21 levels with skeletal muscle mass and mortality in chronic hemodialysis patients. Journal of the Formosan Medical Association 2022. [DOI: 10.1016/j.jfma.2022.05.007] [Reference Citation Analysis]
2 Weng HC, Lu XY, Xu YP, Wang YH, Wang D, Feng YL, Chi Z, Yan XQ, Lu CS, Wang HW. Fibroblast growth factor 21 attenuates salt-sensitive hypertension-induced nephropathy through anti-inflammation and anti-oxidation mechanism. Mol Med 2021;27:147. [PMID: 34773993 DOI: 10.1186/s10020-021-00408-x] [Reference Citation Analysis]